ホーム>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Sulfamethazine

Sulfamethazine (Synonyms: NSC 67457, NSC 683529, Sulfadimethyldiazine, Sulfadimidine)

カタログ番号GC12284

スルファメタジン(スルファジミジン)は、さまざまな動物の病気(胃腸や気道の感染症など)の治療と予防に広く使用されている抗菌薬です。

Products are for research use only. Not for human use. We do not sell to patients.

Sulfamethazine 化学構造

Cas No.: 57-68-1

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$35.00
在庫あり
10mg
$56.00
在庫あり
100mg
$369.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sulfamethazine (Sulfadimidine) is an antimicrobial that is widely used to treat and prevent various animal diseases (such as gastrointestinal and respiratory tract infections). In China and the European Commission, the maximum residue level for Sulfamethazine in animal product is set at 100 µg/kg[1][2].

Sulfamethazine (80 mg/kg; intravenous injection; healthy female pigs) treatment significantly reduces α, β and AUC0->∞, significantly increases t1/2α, Vd and CIB, and upon a single intramuscular administration of 80 mg/kg of Sulfamethazine the absolute bioavailability in pigs is 1.01[1].

References:
[1]. VAN Poucke LSG, et al. Pharmacokinetics and Tissue Residues of Sulfathiazole and Sulfamethazine in Pigs. J Food Prot. 1994 Sep;57(9):796-801.
[2]. Sheng Y J, et al. Production of chicken yolk IgY to sulfamethazine: comparison with rabbit antiserum IgG. Food and Agricultural Immunology. 2015, 26(3):305-316.

レビュー

Review for Sulfamethazine

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sulfamethazine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.